ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

SCLX Scilex Holding Company

0.85
0.00 (0.00%)
Pre Market
Last Updated: 04:49:39
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price 0.86
Ask Price 0.94
News -
Day High

Low
0.8002

52 Week Range

High
8.3699

Day Low
Company Name Stock Ticker Symbol Market Type
Scilex Holding Company SCLX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 0.85 04:49:39
Open Price Low Price High Price Close Price Prev Close
0.85
Trades Volume Avg Volume 52 Week Range
0 0 - 0.8002 - 8.3699
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.85 USD

Scilex Holding Company Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
141.26M 166.19M - 46.74M -114.33M -0.69 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Scilex News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No SCLX Message Board. Create One! See More Posts on SCLX Message Board See More Message Board Posts

Historical SCLX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.161.180.80020.90108971,644,890-0.31-26.72%
1 Month1.601.700.80021.191,042,076-0.75-46.88%
3 Months1.652.630.80021.421,047,693-0.80-48.48%
6 Months1.832.630.80021.45965,213-0.98-53.55%
1 Year6.858.36990.80022.56817,693-6.00-87.59%
3 Years10.0516.200.80023.62669,189-9.20-91.54%
5 Years10.0516.200.80023.62669,189-9.20-91.54%

Scilex Description

Scilex Holding Company is an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. ZTlido (lidocaine topical system) 1.8% is a prescription lidocaine topical product approved by the U.S. Food and Drug Administration for the relief of neuropathic pain associated with post-herpetic neuralgia. We have acquired two FDA approved non-opioid pain products, GLOPERBA and ELYXYB, for the treatment of gout in adults and oral solution for the acute treatment of migraine, with or without aura, in adults. Our product candidates include SP-102 (10 mg, dexamethasone sodium phosphate viscous gel) (SEMDEXA TM), a Phase 3, novel, viscous gel formulation of a widely used corticosteroid for epidural injections to treat lumbosacral radicular pain, or sciatica, SP-103 (lidocaine topical system) 5.

Your Recent History

Delayed Upgrade Clock